Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis

被引:26
作者
Price, Jameca Renee [1 ]
Guran, Larissa A. [3 ]
Gregory, W. Thomas [1 ]
McDonagh, Marian S. [2 ]
机构
[1] Oregon Hlth & Sci Univ, Div Urogynecol & Reconstruct Pelv Surg, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Coll Med, Portland, OR 97201 USA
关键词
adult women; bladder infection; meta-analysis; prophylaxis; recurrence; systematic review; urinary tract infection; MACROCRYSTALLINE NITROFURANTOIN; ANTIBIOTIC-RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE; BACTERIAL CYSTITIS; COMPARATIVE TRIAL; FECAL FLORA; NORFLOXACIN; PREVENTION; MACRODANTIN; THERAPY;
D O I
10.1016/j.ajog.2016.07.040
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The clinical and financial burden from bladder infections is significant. Daily antibiotic use is the recommended strategy for recurrent urinary tract infection prevention. Increasing antibiotic resistance rates, however, require immediate identification of innovative alternative prophylactic therapies. This systematic review aims to provide guidance on gaps in evidence to guide future research. OBJECTIVE: The objective of this review was to provide current pooled estimates of randomized control trials comparing the effects of nitrofurantoin vs other agents in reducing recurrent urinary tract infections in adult, nonpregnant women and assess relative adverse side effects. DATA SOURCES: Data sources included the following: MEDLINE, Jan. 1, 1946, to Jan. 31, 2015; Cochrane Central Register of Controlled Trials the Cochrane Database of Systematic Reviews, and web sites of the National Institute for Clinical Excellence, and the National Guideline Clearinghouse from 2000 to 2015. Randomized control trials of women with recurrent urinary tract infections comparing nitrofurantoin with any other treatment were included. STUDY DESIGN: A protocol for the study was developed a priori. Published guidance was followed for assessment of study quality. All meta-analyses were performed using random-effects models with Stats Direct Software. Dual review was used for all decisions and data abstraction. RESULTS: Twelve randomized control trials involving 1063 patients were included. One study that had a serious flaw was rated poor in quality, one study rated good, and the remainder fair. No significant differences in prophylactic antibiotic treatment with nitrofurantoin and norfloxacin, trimethoprim, sulfamethoxazole/trimethoprim, methamine hippurate, estriol, or cefaclor were found in clinical or microbiological cure in adult nonpregnant women with recurrent urinary tract infections (9 randomized control trials, 673 patients, relative risk ratio, 1.06; 95% confidence interval, 0.89-1.27; I-2, 65%; and 12 randomized control trials, 1063 patients, relative risk ratio, 1.06; 95% confidence interval, 0.90-1.26; I-2, 76%, respectively). Duration of prophylaxis also did not have a significant impact on outcomes. There was a statistically significant difference in overall adverse effects, with nitrofurantoin resulting in greater risk than other prophylactic treatments (10 randomized control trials, 948 patients, relative risk ratio, 2.17; 95% confidence interval, 1.34-3.50; I-2, 61%). Overall, the majority of nitrofurantoin adverse effects were gastrointestinal, with a significant difference for withdrawals (12 randomized control trials, 1063 patients, relative risk ratio, 2.14; 95% confidence interval, 1.28-3.56; I-2, 8%). CONCLUSION: Nitrofurantoin had similar efficacy but a greater risk of adverse events than other prophylactic treatments. Balancing the risks of adverse events, particularly gastrointestinal symptoms, with potential benefits of decreasing collateral ecological damage should be considered if selecting nitrofurantoin.
引用
收藏
页码:548 / 560
页数:13
相关论文
共 50 条
[41]   Recurrent urinary tract infections in women and variations in the antibiotic resistance patterns of their causative agents [J].
Ozkaya, Deniz ;
Gokengin, Deniz .
KLIMIK JOURNAL, 2007, 20 (03) :77-82
[42]   Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis [J].
Scott, Anna Mae ;
Clark, Justin ;
Del Mar, Chris ;
Glasziou, Paul .
BRITISH JOURNAL OF GENERAL PRACTICE, 2020, 70 (692) :E200-E207
[43]   Prevalence and Impact of Biofilms on Bloodstream and Urinary Tract Infections: A Systematic Review and Meta-Analysis [J].
Pinto, Henrique ;
Simoes, Manuel ;
Borges, Anabela .
ANTIBIOTICS-BASEL, 2021, 10 (07)
[44]   Recurrent urinary tract infections in non-pregnant adult women [J].
Henn, E. W. .
SOUTH AFRICAN FAMILY PRACTICE, 2009, 51 (06) :467-470
[45]   Adjuvant treatment with yupingfeng granules for recurrent respiratory tract infections in children: A systematic review and meta-analysis [J].
Zhang, Lu ;
Wang, Xuqiong ;
Wang, Dong ;
Guo, Yinling ;
Zhou, Xinying ;
Yu, Haiyan .
FRONTIERS IN PEDIATRICS, 2022, 10
[46]   Prevalence of antibiotic resistance of Proteus species in urinary tract infections in Iran: A systematic review and meta-analysis [J].
Vaez, Hamid ;
Kalarestaghi, Hossein ;
Sahebkar, Amirhossein ;
Khademi, Farzad .
GENE REPORTS, 2022, 27
[47]   Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis [J].
Cai, Tommaso ;
Anceschi, Umberto ;
Tamanini, Irene ;
Migno, Serena ;
Rizzo, Michele ;
Liguori, Giovanni ;
Garcia-Larrosa, Alejandro ;
Palmieri, Alessandro ;
Verze, Paolo ;
Mirone, Vincenzo ;
Bjerklund Johansen, Truls E. .
ANTIBIOTICS-BASEL, 2022, 11 (01)
[48]   Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies [J].
Fasugba, Oyebola ;
Gardner, Anne ;
Mitchell, Brett G. ;
Mnatzaganian, George .
BMC INFECTIOUS DISEASES, 2015, 15
[49]   Recurrent Uncomplicated Urinary Tract Infections in Women: A Review [J].
Nosseir, Sandy B. ;
Lind, Lawrence R. ;
Winkler, Harvey A. .
JOURNAL OF WOMENS HEALTH, 2012, 21 (03) :347-354
[50]   Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials [J].
Ying-Yu Chen ;
Tsung-Hsien Su ;
Hui-Hsuan Lau .
International Urogynecology Journal, 2021, 32 :17-25